Generation Bio

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Generation Bio and other ETFs, options, and stocks.

About GBIO

Generation Bio Co. is a genetic medicine company focused on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process.

CEO

Cameron Geoffrey McDonough

CEOCameron Geoffrey McDonough

Employees

150

Employees150

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2016

Founded2016

Employees

150

Employees150

GBIO Key Statistics

Market cap

319.25M

Market cap319.25M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

197.15K

Average volume197.15K

High today

$5.43

High today$5.43

Low today

$5.11

Low today$5.11

Open price

$5.18

Open price$5.18

Volume

150.84K

Volume150.84K

52 Week high

$24.43

52 Week high$24.43

52 Week low

$3.96

52 Week low$3.96

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

GBIO Earnings

-$0.66

-$0.44

-$0.22

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, Pre-Market

ActualExpected Nov 9, Pre-Market